CD8A and Sepsis: Longitudinal studies using TCR-transgenic CD8 T cells (i.e., P14) adoptively transferred into C57/Bl6 recipients have shown that the number of both TN and TCIRCM cells quickly bounce back to the pre-sepsis baseline state.